Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 6, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$5.46B
sum of reported positions
Reported positions
130
Changes vs prior quarter
148
31 new · 27 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 180 measured positions in 8 quarters, the typical new or larger position finished −0.3 pts against the S&P 500 and 49% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 996K | $238M | 4.4% | |
| 1.7M | $232M | 4.3% | |
| 968K | $194M | 3.6% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $5.19B | $5.46B |
| Positions | 126 | 130 |
| Biggest line | — | Amazon 4% |
| 933K |
| $187M |
| 3.4% |
| 3.98M | $185M | 3.4% |
| 2.68M | $184M | 3.4% |
| 11.1M | $178M | 3.3% |
| 1.77M | $164M | 3.0% |
| 395K | $147M | 2.7% |
| 1.29M | $145M | 2.7% |
| 1.1M | $141M | 2.6% |
| 3.84M | $141M | 2.6% |
| 375K | $131M | 2.4% |
| 1.67M | $127M | 2.3% |
| 3.27M | $125M | 2.3% |
| 1.09M | $125M | 2.3% |
FOMENTO ECONOMICO MEXICANO S | 951K | $122M | 2.2% |
| 290K | $113M | 2.1% |
| 1.61M | $110M | 2.0% |
| 1.76M | $107M | 2.0% |
| 435K | $104M | 1.9% |
| 814K | $103M | 1.9% |
| 2.16M | $103M | 1.9% |
| 182K | $102M | 1.9% |
| 1.88M | $102M | 1.9% |
Americold Realty Trust (COLD)
1.16M shares in Q1 2026
Oracle (ORCL)
212K shares in Q1 2026
Honeywell International Inc
161K shares in Q1 2026
Clipper Realty (CLPR)
126K shares in Q1 2026
Lsb Industries (LXU)
102K shares in Q1 2026
LegalZoom.com, Inc. (LZ)
80K shares in Q1 2026
Otis Worldwide (OTIS)
62K shares in Q1 2026
Power Solutions International (PSIX)
53K shares in Q1 2026
Stoneco (STNE)
46K shares in Q1 2026
Alcon (ALC)
27K shares in Q1 2026
Vnet Group (VNET)
14K shares in Q1 2026
Cabaletta Bio (CABA)
5,616 shares in Q1 2026
Teva Pharmaceutical Industries
2,234 shares in Q1 2026
Oric Pharmaceuticals (ORIC)
1,278 shares in Q1 2026
Boston Scientific (BSX)
1,128 shares in Q1 2026
Ideaya Biosciences (IDYA)
917 shares in Q1 2026
Bioage Labs (BIOA)
915 shares in Q1 2026
Viridian Therapeutics, Inc. (VRDN)
834 shares in Q1 2026
Irhythm Holdings (IRTC)
655 shares in Q1 2026
AutoZone (AZO)
640 shares in Q1 2026
Gilead Sciences (GILD)
557 shares in Q1 2026
Tarsus Pharmaceuticals (TARS)
555 shares in Q1 2026
Dexcom (DXCM)
554 shares in Q1 2026
Disc Medicine (IRON)
476 shares in Q1 2026
Terns Pharmaceuticals Inc
455 shares in Q1 2026
